Showing 14,601 - 14,620 results of 105,702 for search '(( 50 ((mean decrease) OR (we decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.55s Refine Results
  1. 14601

    Image_1_A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With S... by Johanna Reinold (11716253)

    Published 2021
    “…The gut microbiome in SARS-CoV-2 infected patients was characterized by a lower bacterial richness and distinct differences in the gut microbiome composition, including an enrichment of the phyla Proteobacteria and Bacteroidetes and a decrease of Actinobacteria compared to SARS-CoV-2 negative patients. …”
  2. 14602

    Image_3_A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With S... by Johanna Reinold (11716253)

    Published 2021
    “…The gut microbiome in SARS-CoV-2 infected patients was characterized by a lower bacterial richness and distinct differences in the gut microbiome composition, including an enrichment of the phyla Proteobacteria and Bacteroidetes and a decrease of Actinobacteria compared to SARS-CoV-2 negative patients. …”
  3. 14603

    Image_2_A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With S... by Johanna Reinold (11716253)

    Published 2021
    “…The gut microbiome in SARS-CoV-2 infected patients was characterized by a lower bacterial richness and distinct differences in the gut microbiome composition, including an enrichment of the phyla Proteobacteria and Bacteroidetes and a decrease of Actinobacteria compared to SARS-CoV-2 negative patients. …”
  4. 14604

    Flow diagram of the study population. by Dina Evyana (18462048)

    Published 2024
    “…Patients with a PASI score>10 had a significantly higher risk of metabolic syndrome compared to those with a score ≤ 10 (78.6% vs 50%, OR 3.667; 95% CI 1.413–9.514; <i>p</i> = 0.006). …”
  5. 14605

    Bcl-xL protein levels were decreased in response to siRNA transfection in A549, SK-LU1 and NP-69 cells. by Norahayu Othman (495150)

    Published 2013
    “…<p>(<b>A</b>) Western blot indicating a significant decrease in Bcl-xL protein levels in comparison to non-transfected cells 48 h post-transfection. …”
  6. 14606

    Identification of Chz1 regions dictates the preference for H2A.Z. (A) Schematic view of Chz1-FL according to a previous mapping result. by Yunyun Wang (317888)

    Published 2019
    “…(C) Effect of Chz1-MC and Chz1-M on dictating the preference for H2A.Z. The folds of binding affinity decrease between all histone dimers (in single-chain form) and scZB are denoted as Kd/Kd (H2A.Z) and calculated for comparison. …”
  7. 14607

    Effect of telomerase siRNA transfection on AFP production by HepG2/C3A and PLC/PRF/5 cells. by Roula Tahtouh (714734)

    Published 2015
    “…(A) The inhibition of telomerase by hTERT siRNA induced a decrease in AFP production by HepG2/C3A cells. …”
  8. 14608

    Temporal trend of ∑DDT levels in osprey eggs in different study areas and all areas combined (lower graph). by Matti Viluksela (321291)

    Published 2024
    “…∑DDT concentrations decreased significantly in the whole dataset (annual decrease 8.1%) and in all study areas (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0308227#pone.0308227.g015" target="_blank">Fig 15</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0308227#pone.0308227.t002" target="_blank">Table 2</a>). …”
  9. 14609

    Data Sheet 1_Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer’s disease.xlsx by Demos Kynigopoulos (12420457)

    Published 2025
    “…</p>Methods<p>We investigated the effects of two FDA-approved metabolic agents—Alirocumab, a PCSK9 inhibitor that lowers LDL cholesterol, and Gliclazide, a sulfonylurea that enhances insulin secretion—in male 5xFAD mice, a transgenic model of AD. …”
  10. 14610

    Supplementary file 1_Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer’s disease.docx by Demos Kynigopoulos (12420457)

    Published 2025
    “…</p>Methods<p>We investigated the effects of two FDA-approved metabolic agents—Alirocumab, a PCSK9 inhibitor that lowers LDL cholesterol, and Gliclazide, a sulfonylurea that enhances insulin secretion—in male 5xFAD mice, a transgenic model of AD. …”
  11. 14611

    Individual data and box plots on ∑PBB of all samples. by Matti Viluksela (321291)

    Published 2024
    “…<p>Individual data (A) indicate an increase in the early 1980’s, a peak in mid-late 1990’s followed by a decrease depending on study area. …”
  12. 14612
  13. 14613

    Temporal trend of ∑PBB levels in osprey eggs in the whole dataset and in different study areas. by Matti Viluksela (321291)

    Published 2024
    “…Regression analysis showed significantly increased ∑PBB concentrations in the whole dataset (annual increase 5.6%), in Lake Vanajanselkä (8.7%) and in Pristine SW Lake Area (6.5%), but the smoother explained significantly more of the variation in concentration over time showing a decrease in ∑PBB levels towards the end of the observation period.…”
  14. 14614
  15. 14615
  16. 14616

    Degradation of a VX Analogue: First Organometallic Reagent To Promote Phosphonothioate Hydrolysis Through Selective P−S Bond Scission by Louis Y. Kuo (1915309)

    Published 2008
    “…We report the first case of a metal complex that degrades a neurotoxin mimic under extremely mild conditions (pH 6.8, room temperature). …”
  17. 14617
  18. 14618
  19. 14619
  20. 14620